ArticleFrontiers in cardiovascular medicine2023
Predicting 7-day unplanned readmission in elderly patients with coronary heart disease using machine learning.
Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 9 citations in OpenAlex.
- Computational approaches to multimodal data integration in rheumatoid arthritis: from data landscape to clinical translation.Briefings in bioinformatics · 2026Review
- Machine learning-based coronary heart disease diagnosis model for type 2 diabetes patients.Frontiers in endocrinology · 2025Article
- Systematic Review and Critical Appraisal of Prediction Models for Readmission in Coronary Artery Disease Patients: Assessing Current Efficacy and Future Directions.Risk management and healthcare policy · 2024Review
- A cost-sensitive deep neural network-based prediction model for the mortality in acute myocardial infarction patients with hypertension on imbalanced data.Frontiers in cardiovascular medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Short-term unplanned readmission is always neglected, especially for elderly patients with coronary heart disease (CHD). However, tools to predict unplanned readmission are lacking. This study aimed to establish the most effective predictive model for the unplanned 7-day readmission in elderly CHD patients using machine learning (ML) algorithms. Methods: The detailed clinical data of elderly CHD patients were collected retrospectively. Five ML algorithms, including extreme gradient boosting (XGB), random forest, multilayer perceptron, categorical boosting, and logistic regression, were used to establish predictive models. We used the area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, the F1 value, the Brier score, the area under the precision-recall curve (AUPRC), and the calibration curve to evaluate the performance of ML models. The SHapley Additive exPlanations (SHAP) value was used to interpret the best model. Results: The final study included 834 elderly CHD patients, whose average age was 73.5 ± 8.4 years, among whom 426 (51.08%) were men and 139 had 7-day unplanned readmissions. The XGB model had the best performance, exhibiting the highest AUC (0.9729), accuracy (0.9173), F1 value (0.9134), and AUPRC (0.9766). The Brier score of the XGB model was 0.08. The calibration curve of the XGB model showed good performance. The SHAP method showed that fracture, hypertension, length of stay, aspirin, and D-dimer were the most important indicators for the risk of 7-day unplanned readmissions. The top 10 variables were used to build a compact XGB, which also showed good predictive performance. Conclusions: In this study, five ML algorithms were used to predict 7-day unplanned readmissions in elderly patients with CHD. The XGB model had the best predictive performance and potential clinical application perspective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.